dsm-firmenich stock
DSFIR.ASAMSdsm-firmenich AG, Basic MaterialsISIN CH1216478797
57Score 57 out of 100, Neutral
Price and trend
81 / 100
Price history
+43% in one yearThe chart shows daily closes over 4 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 32% above it.
Since June 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 42).
The price is 7.2% below its 52-week high. Largest decline in 4 years: 55% (September 2024 to March 2026).
Chart figures for advanced users
- SMA 50$112.22
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$88.92
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)42
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$61.67
- The lowest closing price of the last twelve months.
- Resistance$126.07
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- dsm-firmenich AG belongs to the Chemicals (Specialty) industry (Switzerland) and, with a market value of $28.59B, is number 9 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $10.05B (down 0.2% year on year) and a loss of $1.2B.
- MEQIRI Score 57 out of 100 (Neutral): rank 247 of 467 in Basic Materials, median 58.
Show more
- The P/E is 226.8 because earnings over the last twelve months collapsed; on the expected earnings of the next twelve months it is 26.1 (Chemicals (Specialty) median 24.4). The P/E therefore does not count in the score.
- Our model puts fair value at $135.60, with the price 13% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 15.1% a year through 2028 (estimates from 18 analysts).
Weaknesses
- DilutionShare count up 50% since 2020.Capital allocation 20
- Loss-makingLoss of $1.42B over the last 12 months.Fundamentals 66
- Dividend not coveredDividend paid despite a loss over the last 12 months; payouts were 123% of free cash flow.Capital allocation 20
Its standout strengths are momentum and technical analysis, while profitability and capital allocation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among stocks ranked 101 to 1,000.
From 2016 to 2025, 13 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- price near its 52-week high
Valuation
Valuation signal
Fairly valuedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $104.31 and expensive above $193.71 (uncertainty medium, based on the price swings of the past year).
Calculated with a cost of equity of 7.1%. At 8.1% the fair value would be $113.02, at 6.1% it would be $169.45.
Valuation metrics
From the cash-flow model alone; after a one-off collapse in earnings there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the quarter to 30 Jun 2026, revenue rose 43.3% on the same quarter a year earlier. Revenue has changed sharply in recent years: $10.05B in 2025 after $11.82B in 2023.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 39%, operating 8%, net not measured.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 18 Feb 2027in 98 days
- Last reported
- 30 Jul 2026EPS reported $1.31 (expected $1.91)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $4.05−1.2%
- Revenue
- $10.35B+0.3%
- Earnings per share
- $4.55−0.7%
- Revenue
- $10.87B+0.4%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at dsm-firmenich
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 57
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Air Products and ChemicalsAPD $70.19B47
- GivaudanGIVN.SW $45.43B73
- SikaSIKA.SW $37.55B68
- Wanhua Chemical Group600309.SS $32.8B60
- NovozymesNSIS-B.CO $27.79B54
- PPG IndustriesPPG $27.61B70
- Asian PaintsASIANPAINT.NS $26.09B67
- Ems-Chemie HoldingEMSN.SW $23.84B74
ETFs that hold dsm-firmenich
Held by 136 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares STOXX Europe 600 Food & Beverage UCITS ETF (DE)EXH3 | 3.96% | 0.46% | €353.84M |
| State Street SPDR MSCI Europe Materials UCITS ETFSPYP | 2.75% | 0.18% | €109.81M |
| Xtrackers MSCI Europe Materials Screened UCITS ETF 1CDXSC | 2.59% | 0.17% | €66.76M |
Show 5 more
| iShares MSCI EMU Mid Cap UCITS ETF EURIS3H | 1.52% | 0.49% | €567.29M |
| Amundi MSCI EMU SRI Climate Paris Aligned UCITS ETF DR (C)SRHE | 1.21% | 0.18% | €119.46M |
| UBS MSCI EMU Socially Responsible UCITS ETF A DistributionUIMR | 1.16% | 0.20% | €1.22B |
| WisdomTree Europe Equity UCITS ETF USD HedgedWTDH | 0.93% | 0.58% | €117.51M |
| Deka MSCI Europe MC UCITS ETFEL43 | 0.83% | 0.36% | €67.17M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.